Clinical Trials
3 trialsNCT06639074 2025-10-02
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Mayo Clinic
Phase 2 Recruiting
NCT00639639 2023-03-13
ATTAC
Duke University
Phase 1 Completed
NCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed